Hormel Foods faces volatility in key markets but has near-term support. Read why HRL stock could be a hold as risks and ...
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
UBS raised the firm’s price target on Palo Alto Networks (PANW) to $200 from $190 and keeps a Neutral rating on the shares. Palo Alto reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results